TrialDiabetes care2012

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition.

Maria Rosaria Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.